Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

SHBG may be a useful early indicator and treatment target for PCOS.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Terbinafine can cause hair loss.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Almond oil works well as a biodegradable lubricant and has health benefits.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.